Cyclamen coum
Cyclamen coum · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Cyclamen coum is a remarkable plant species that has garnered significant scientific interest due to its diverse pharmacological potential. Recent studies have focused on evaluating its anticancer activities, specifically targeting various cellular pathologies. Research has demonstrated that its extract shows promise in addressing conditions such as candidiasis and cervical cancer. Furthermore, experimental observations have highlighted its specific impact on the growth of HeLa cells. These findings suggest that the plant holds substantial therapeutic value for future medicinal developments.
- Synonyms
- Cyclaminus Coum
- Common names
- Not available
- Family
- Primulaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Cyclamen coum is a versatile plant known by a diverse array of regional and descriptive common names. In certain areas, it is affectionately referred to as Ciclamino di Cos or Cyclamen de Cos. It is also widely recognized by its more descriptive titles, such as Eastern Cyclamen and Eastern Sowbread. Interestingly, the plant holds a unique cultural identity in Wales, where it is called Bara'r-Hwch y Gaeaf. These various names highlight the plant's widespread presence and the different ways it is cherished across various landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Cyclamen coum is a charming perennial known for its delicate blooms and unique foliage. In botanical literature, you may occasionally encounter this species referred to by its synonym, Cyclaminus coum. While both names describe the same resilient plant, the former is the more widely accepted scientific designation. Understanding these nomenclatural relationships is essential for gardeners and botanists tracking plant varieties accurately. Recognizing these synonyms ensures that enthusiasts can successfully identify and cultivate this beautiful species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Cyclamen coum belongs to the vast kingdom Plantae, marking its place among the diverse world of living plants. Within this kingdom, it is classified under the class Equisetopsida and falls into the order Ericales. The species is a distinguished member of the family Primulaceae, showcasing unique botanical characteristics. Further narrowing its biological identity, it is categorized under the genus Cyclamen. Understanding these taxonomic relationships provides essential insight into the evolutionary lineage of this beautiful plant.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Primulaceae |
| Genus | Cyclamen |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cyclamen coum is widely distributed throughout the temperate regions of Asia, spanning several distinct ecological zones. Its range extends through the Caucasus and Transcaucasus, establishing a strong presence in these mountainous areas. In Western Asia, the species can be found across the landscapes of Türkiye and the Lebanon-Syria border. Furthermore, its natural habitat reaches southward into Palestine, demonstrating significant geographical versatility. This widespread distribution highlights the plant's ability to thrive in diverse environments across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Cyclamen coum is a delicate herb characterized by its compact and low-growing habit. This species typically reaches a modest height, generally staying well below the quarter-meter mark. Depending on its environment, the plant usually fluctuates between a minimum height of 0.06 m and a maximum of 0.22 m.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Cyclamen coum is a traditional medicinal plant endemic to Turkey that shows significant promise in oncological research. Recent studies have investigated its potential anticancer properties by examining its cytotoxic effects on various solid tumor cell lines. Experimental results demonstrate that extracts from this plant induce cellular death in both HeLa cervical cancer and H1299 non-small cell lung cancer cells in a dose-dependent manner. Furthermore, the research reveals that this cytotoxicity occurs specifically through the induction of apoptosis. These findings suggest that the plant could serve as a valuable source for discovering novel anticancer compounds in the future.
Compounds
Conditions
Cyclamen coum tuber extracts demonstrate significant antifungal activity against various Candida strains, providing a potential herbal treatment for Candidiasis. Specifically, the plant's triterpenoid saponins have shown the ability to treat C. albicans. Research further indicates that these extracts are effective in treating C. krusei. Additionally, the medicinal properties of the plant are useful for treating C. tropicalis 0750. These results highlight the effectiveness of Cyclamen coum in combating these specific fungal pathogens.
Preparations
Cyclamen coum is prepared as an extract to investigate its potential therapeutic properties in medicinal research. This specific preparation allows scientists to test the plant's effects on various solid tumor cell lines, such as HeLa and H1299. By utilizing the plant in extract form, researchers were able to observe dose-dependent cellular death and apoptosis. The process of creating this extract is a critical step in identifying whether the endemic species contains novel anticancer compounds. Consequently, the preparation of the extract serves as the foundation for evaluating the plant's cytotoxic capabilities.